Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Mainz Biomed B.V.

    NASDAQ: MYNZ · Real-Time Price · USD
    1.62
    -0.21 (-11.48%)
    At close: Jun 16, 2025, 3:59 PM
    1.72
    6.17%
    Pre-market: Jun 17, 2025, 08:34 AM EDT

    Mainz Biomed B.V. Statistics

    Share Statistics

    Mainz Biomed B.V. has 3.81M shares outstanding. The number of shares has increased by -89.85% in one year.

    Shares Outstanding

    n/a
    		 3.81M

    Shares Change (YoY)

    n/a
    		 -89.85%

    Shares Change (QoQ)

    n/a
    		 10.94%

    Owned by Institutions (%)

    n/a
    		 1.03%

    Shares Floating

    n/a
    		 3.62M

    Failed to Deliver (FTD) Shares

    n/a
    		 2,743

    FTD / Avg. Volume

    n/a
    		 1.6%

    Short Selling Information

    The latest short interest is 39.35K, so 1.03% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 39.35K

    Short % of Shares Out

    n/a
    		 1.03%

    Short % of Float

    n/a
    		 1.05%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.19 and the forward PE ratio is -0.96. Mainz Biomed B.V.'s PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.19

    Forward PE

    n/a
    		 -0.96

    PS Ratio

    n/a
    		 4.68

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0.69

    P/FCF Ratio

    n/a
    		 -0.24

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Mainz Biomed B.V..

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.54.

    Current Ratio

    n/a
    		 1.32

    Quick Ratio

    n/a
    		 1.26

    Debt / Equity

    n/a
    		 0.54

    Debt / EBITDA

    n/a
    		 -0.17

    Debt / FCF

    n/a
    		 -0.19

    Interest Coverage

    n/a
    		 -17.39

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $47,052.16

    Profits Per Employee

    n/a
    		 $-1,139,508.58

    Employee Count

    n/a
    		 19

    Asset Turnover

    n/a
    		 0.07

    Inventory Turnover

    n/a
    		 0.86

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -93.25% in the last 52 weeks. The beta is 0.3, so Mainz Biomed B.V.'s price volatility has been higher than the market average.

    Beta

    n/a
    		 0.3

    52-Week Price Change

    n/a
    		 -93.25%

    50-Day Moving Average

    n/a
    		 2.6

    200-Day Moving Average

    n/a
    		 6.44

    Relative Strength Index (RSI)

    n/a
    		 26.1

    Average Volume (20 Days)

    n/a
    		 171,036

    Income Statement

    In the last 12 months, Mainz Biomed B.V. had revenue of 893.99K and earned -21.65M in profits. Earnings per share was -22.36.

    Revenue

    n/a
    		 893.99K

    Gross Profit

    n/a
    		 574.88K

    Operating Income

    n/a
    		 -18.7M

    Net Income

    n/a
    		 -21.65M

    EBITDA

    n/a
    		 -19.56M

    EBIT

    n/a
    		 -20.58M

    Earnings Per Share (EPS)

    n/a
    		 -22.36
    Full Income Statement

    Balance Sheet

    The company has 6.24M in cash and 3.27M in debt, giving a net cash position of 2.96M.

    Cash & Cash Equivalents

    n/a
    		 6.24M

    Total Debt

    n/a
    		 3.27M

    Net Cash

    n/a
    		 2.96M

    Retained Earnings

    n/a
    		 -90.98M

    Total Assets

    n/a
    		 13.24M

    Working Capital

    n/a
    		 1.89M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -17.09M and capital expenditures -254.95K, giving a free cash flow of -17.34M.

    Operating Cash Flow

    n/a
    		 -17.09M

    Capital Expenditures

    n/a
    		 -254.95K

    Free Cash Flow

    n/a
    		 -17.34M

    FCF Per Share

    n/a
    		 -17.91
    Full Cash Flow Statement

    Margins

    Gross margin is 64.31%, with operating and profit margins of -2091.23% and -2421.8%.

    Gross Margin

    n/a
    		 64.31%

    Operating Margin

    n/a
    		 -2091.23%

    Pretax Margin

    n/a
    		 -2421.8%

    Profit Margin

    n/a
    		 -2421.8%

    EBITDA Margin

    n/a
    		 -2187.76%

    EBIT Margin

    n/a
    		 -2091.23%

    FCF Margin

    n/a
    		 -1940.17%

    Dividends & Yields

    MYNZ does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for MYNZ is $14, which is 764.2% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $14

    Price Target Difference

    n/a
    		 764.2%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Dec 3, 2024. It was a backward split with a ratio of 1:40.

    Last Split Date

    n/a
    		 Dec 3, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:40

    Scores

    Altman Z-Score

    n/a
    		 -18.33

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist